These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2338287)

  • 21. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
    Pogrebniak A; Schemainda I; Azzam K; Pelka-Fleischer R; Nüssler V; Hasmann M
    Eur J Med Res; 2006 Aug; 11(8):313-21. PubMed ID: 17052966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
    Gidáli J; Fehér I; Kovács P
    Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular and pharmacologic aspects of drug resistance in acute myeloid leukemia.
    Ross DD
    Curr Opin Oncol; 1991 Feb; 3(1):21-9. PubMed ID: 1675126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells.
    Sachlos E; Risueño RM; Laronde S; Shapovalova Z; Lee JH; Russell J; Malig M; McNicol JD; Fiebig-Comyn A; Graham M; Levadoux-Martin M; Lee JB; Giacomelli AO; Hassell JA; Fischer-Russell D; Trus MR; Foley R; Leber B; Xenocostas A; Brown ED; Collins TJ; Bhatia M
    Cell; 2012 Jun; 149(6):1284-97. PubMed ID: 22632761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lobular panniculitis terminating in acute myeloid leukemia.
    Fujiwara S; Hosokawa T; Akizuki S; Itami S; Yamamura T; Kuroda A; Matsunaga E; Shinkai H; Takayasu S
    Int J Dermatol; 1991 Jul; 30(7):503-4. PubMed ID: 1769775
    [No Abstract]   [Full Text] [Related]  

  • 26. Development of drug resistance in cultured clonogenic leukemic blast cells during the clinical course of myeloblastic leukemia.
    Asano Y; Okamura S; Shibuya T; Morioka E; Hirota Y; Niho Y
    Oncology; 1989; 46(5):339-42. PubMed ID: 2779949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of two assays for the in vitro chemosensitivity testing of human acute non-lymphoblastic leukemia cells.
    Dal Pozzo O; Bernabei PA; Santini V; Saccardi R; Santini S; Rossi Ferrini P
    J Chemother; 1989 Oct; 1(5):318-23. PubMed ID: 2585033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pretherapeutic sensitivity tests of human leukemia cells against cytostatic drugs in vitro in relation to the in vivo effects].
    Hirschmann WD; Gross R
    Med Welt; 1976 Nov; 27(47):2298-9. PubMed ID: 1004180
    [No Abstract]   [Full Text] [Related]  

  • 29. [Growth inhibition of human myeloid leukemia cells in vitro by harringtonine].
    Piao YF; Okabe T; Zhang LJ
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):281-5. PubMed ID: 2301953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukemia cell lines resistant to cytosine arabinoside, cyclophosphamide or daunomycin are equally sensitive to the drug acetyldinaline as the parental cell line.
    El-Beltagi HM; Martens AC; Hagenbeek A
    Leukemia; 2000 Jan; 14(1):213-4. PubMed ID: 10637498
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of cytosine arabinoside on leukemic blast cell colonies.
    Iacopino P; Comis M; Abenavoli MR; Neri A
    Am J Hematol; 1986 Jun; 22(2):219-20. PubMed ID: 3706294
    [No Abstract]   [Full Text] [Related]  

  • 32. Secondary refractory anemia with excess of blasts in transformation terminating as acute lymphoblastic leukemia.
    Nagler A; Brenner B; Tatarsky I
    Acta Haematol; 1986; 76(2-3):164-5. PubMed ID: 3101358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analytical and pharmacological studies on a new antineoplastic tripeptide, PTT.119.
    Roboz J; Greaves J; Yagi MJ; Holland JF; Bekesi JG
    Pharmacology; 1985; 30(1):52-9. PubMed ID: 3975256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased cancericidal activity of PTT.119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. I. In vitro cytotoxicity.
    Yagi MJ; Bekesi JG; Daniel MD; Holland JF; De Barbieri A
    Cancer Chemother Pharmacol; 1984; 12(2):70-6. PubMed ID: 6421500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of single-stranded DNA damage using monoclonal anti-thymidine antibody.
    Raza A; Mehdi I; Guo WJ; Yousuf N; Masterson M; Mirto S; Motyka LE; Mayers GL
    Leuk Res; 1991; 15(1):9-17. PubMed ID: 1997746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Test this patient's leukemic stem cells in a non-clonogenic chemosensitivity assay, treat according to standard protocols.
    Hofmann V; Berens ME
    Eur J Cancer Clin Oncol; 1984 Sep; 20(9):1119-21. PubMed ID: 6541132
    [No Abstract]   [Full Text] [Related]  

  • 37. Evidence for increased intracellular transport of m-sarcolysine (alkylating moiety) when combined with two amino acid analogs (PTT-119).
    Verlicchi F; Boschi S; Visani G; Guidi A; Tosi P; Cavo M; Tura S
    Blut; 1990 Nov; 61(5):311-3. PubMed ID: 2271778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of PTT 119 activity on acute nonlymphoblastic leukemia cells by [3H]-thymidine uptake inhibition and cluster analysis.
    Dal Pozzo O; Santini V; Saccardi R; Bernabei PA; Rossi Ferrini P
    Haematologica; 1990; 75(1):50-3. PubMed ID: 2338287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of the short term predictive assay in the inductive treatment of patients with acute nonlymphoblastic leukemia.
    Mardiak J; Ujházy V
    Neoplasma; 1986; 33(6):723-30. PubMed ID: 3808127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.